Bharat Parenterals Limited submitted a regulatory disclosure to BSE Limited under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with Regulation 6(2) for continual disclosure.
The filing specifically details a change in securities holding by a promoter entity of the company.
Details of Securities Acquisition
Acquiring Entity: Desai Shares and Stock Private Limited (represented by Mr. Bhahim Desai)
Category of Person: Promoter
ISIN of Company: INE365Y01019
Securities Held Prior to Acquisition:
- Type of Security: Equity Shares
- Number of Securities: 27,31,536
- Percentage of Shareholding: 39.63%
Securities Acquired:
- Type of Security: Equity Shares
- Number of Securities Acquired: 900
- Transaction Value: ₹12,62,164 (excluding taxes, brokerage, and other charges)
- Transaction Type: Purchase
- Mode of Acquisition: On Market
- Exchange: BSE
Securities Held Post Acquisition:
- Type of Security: Equity Shares
- Number of Securities: 27,32,436
- Percentage of Shareholding: 39.65%
Transaction Timeline:
- Acquisition Period: From June 03, 2026 to June 12, 2026
- Date of Intimation to Company: June 15, 2026
Derivatives Trading
No trading in derivatives on the company's securities was reported by the promoter. The section is marked as "Not Applicable."
Filing and Authentication
The disclosure was signed by Mr. Bhahim Desai, Director, on June 15, 2026, in Vadodara. The compliance submission to BSE was digitally signed by Sharmin Nareshkumar Soni, Company Secretary & Compliance Officer (ICSI Membership No: A75694), on June 16, 2026.
The document is also available on the company's website at www.bplindia.in.